MICA*012:01Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer

被引:9
|
作者
Ding, Weifeng [1 ,2 ]
Ma, Yanyun [3 ]
Zhu, Weifeng [4 ]
Pu, Weilin [3 ]
Zhang, Jianfeng [5 ]
Qian, Fei [6 ]
Zhou, Youlang [7 ]
Deng, Yan [8 ]
Guo, Shicheng [9 ]
Wang, Jiucun [3 ,10 ,11 ]
Zhou, Xiaodong [2 ]
机构
[1] Nantong Univ, Dept Lab Med, Affiliated Hosp, Nantong, Peoples R China
[2] Univ Texas Houston, McGovern Med Sch, Houston, TX 77030 USA
[3] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China
[4] Nanchang Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Nanchang, Jiangxi, Peoples R China
[5] Nantong Univ, Dept Gastroenterol, Affiliated Hosp, Nantong, Peoples R China
[6] Nantong Univ, Dept Gastrointestinal Surg, Affiliated Hosp, Nantong, Peoples R China
[7] Nantong Univ, Hand Surg Res Ctr, Dept Hand Surg, Affiliated Hosp, Nantong, Peoples R China
[8] Nanchang Univ, Dept Ophthalmol Children, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China
[9] Marshfield Clin Fdn Med Res & Educ, Ctr Precis Med Res, Res Inst, Marshfield, WI USA
[10] Fudan Univ, Inst Rheumatol Immunol & Allergy, Shanghai, Peoples R China
[11] Fudan Univ, Human Phenome Inst, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
MICA polymorphism; colorectal cancer; MICA*012; 01allele; immunosurveillance; tumor immunity; E-CADHERIN; MICA; NKG2D; OVEREXPRESSION; SUSCEPTIBILITY; POLYMORPHISM; STATISTICS; EXPRESSION; DISEASE; TUMOR;
D O I
10.3389/fgene.2020.00511
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Major histocompatibility complex (HLA) class I chain-related protein A (MICA) regulates immune surveillance through activation of NKG2D (natural killer group 2D) receptor. However, the genetic association, potential function, and predictive ability of MICA alleles with colorectal cancer (CRC) prognosis remain undefined. In this study, we characterized MICA alleles in tissue samples from 104 patients with CRC and 536 healthy controls and carried out genetic association studies by molecular and clinical CRC phenotypes. Preliminary sequence analysis revealed thatMICA*009:01or*049alleles were significantly decreased in patients with CRC (p= 0.0049), and further stratification analysis indicated thatMICA*012:01allele was associated with patients with CRC and carrying KRAS codon 12 mutation (p= 0.027). The functional consequences of MICA alleles were examined via transfected CRC cell lines which showed that overexpression ofMICA*012:01enhanced the proliferation, invasion, and metastatic phenotype of CRC. Preliminary analysis of disease-free survival time in patients with and withoutMICA*012:01suggest this allele may be predictive for poor prognosis of patients with KRAS codon 12 mutated CRC, as no somatic mutation of MICA gene was detected in CRC tumors compared to paracancerous tissues. Our study indicates thatMICA*012:01allele is associated with KRAS-mutated CRC, facilitates CRC invasion and metastasis, and possibly reduces the survival of patients with KRAS-mutated CRC.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
    Qiming Zhou
    Yao Peng
    Fenfen Ji
    Huarong Chen
    Wei Kang
    Lam-Shing Chan
    Hongyan Gou
    Yufeng Lin
    Pingmei Huang
    Danyu Chen
    Qinyao Wei
    Hao Su
    Cong Liang
    Xiang Zhang
    Jun Yu
    Chi Chun Wong
    Nature Communications, 14
  • [32] Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
    Zhou, Qiming
    Peng, Yao
    Ji, Fenfen
    Chen, Huarong
    Kang, Wei
    Chan, Lam-Shing
    Gou, Hongyan
    Lin, Yufeng
    Huang, Pingmei
    Chen, Danyu
    Wei, Qinyao
    Su, Hao
    Liang, Cong
    Zhang, Xiang
    Yu, Jun
    Wong, Chi Chun
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [33] A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer
    Bangi, Erdem
    Ang, Celina
    Smibert, Peter
    Uzilov, Andrew V.
    Teague, Alexander G.
    Antipin, Yevgeniy
    Chen, Rong
    Hecht, Chana
    Gruszczynski, Nelson
    Yon, Wesley J.
    Malyshev, Denis
    Laspina, Denise
    Selkridge, Isaiah
    Rainey, Hope
    Moe, Aye S.
    Lau, Chun Yee
    Taik, Patricia
    Wilck, Eric
    Bhardwaj, Aarti
    Sung, Max
    Kim, Sara
    Yum, Kendra
    Sebra, Robert
    Donovan, Michael
    Misiukiewicz, Krzysztof
    Schadt, Eric E.
    Posner, Marshall R.
    Cagan, Ross L.
    SCIENCE ADVANCES, 2019, 5 (05):
  • [34] Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
    Wagner, Steve
    Vlachogiannis, Georgios
    Brandon, Alexis De Haven
    Valenti, Melanie
    Box, Gary
    Jenkins, Liam
    Mancusi, Caterina
    Self, Annette
    Manodoro, Floriana
    Assiotis, Ioannis
    Robinson, Penny
    Chauhan, Ritika
    Rust, Alistair G.
    Matthews, Nik
    Eason, Kate
    Khan, Khurum
    Starling, Naureen
    Cunningham, David
    Sadanandam, Anguraj
    Isacke, Clare M.
    Kirkin, Vladimir
    Valeri, Nicola
    Whittaker, Steven R.
    ONCOGENE, 2019, 38 (10) : 1717 - 1733
  • [35] Suppression of inflammatory gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
    Wagner, Steve
    Vlachogiannis, George
    Brandon, Alexis de Haven
    Valenti, Melanie
    Box, Gary
    Jenkins, Liam
    Mancusi, Caterina
    Self, Annette
    Chauhan, Ritika
    Rust, Alistair
    Matthews, Nik
    Eason, Kate
    Sadanandam, Anguraj
    Isacke, Clare
    Kirkin, Vladimir
    Valeri, Nicola
    Whittaker, Steven R.
    CANCER RESEARCH, 2018, 78 (13)
  • [36] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Xiufeng Pang
    Mingyao Liu
    Chinese Journal of Cancer, 2016, 35 (11) : 571 - 573
  • [37] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Pang, Xiufeng
    Liu, Mingyao
    CHINESE JOURNAL OF CANCER, 2016, 35 : 92
  • [38] The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer
    Tanjak, Pariyada
    Chaiboonchoe, Amphun
    Suwatthanarak, Tharathorn
    Acharayothin, Onchira
    Thanormjit, Kullanist
    Chanthercrob, Jantappapa
    Suwatthanarak, Thanawat
    Wannasuphaphol, Bundit
    Chumchuen, Kemmapon
    Suktitipat, Bhoom
    Sampattavanich, Somponnat
    Korphaisarn, Krittiya
    Pongpaibul, Ananya
    Poungvarin, Naravat
    Grove, Harald
    Riansuwan, Woramin
    Trakarnsanga, Atthaphorn
    Methasate, Asada
    Pithukpakorn, Manop
    Chinswangwatanakul, Vitoon
    CANCERS, 2023, 15 (04)
  • [39] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
  • [40] Quercetin preferentially induces apoptosis in KRAS-mutant colorectal cancer cells via JNK signaling pathways
    Yang, Yiwen
    Wang, Tao
    Chen, Degao
    Ma, Qizhao
    Zheng, Yanjiang
    Liao, Shiping
    Wang, Yufang
    Zhang, Ji
    CELL BIOLOGY INTERNATIONAL, 2019, 43 (02) : 117 - 124